CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation

CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation

Background: Heart transplantation is an emergency surgery requiring cardio-pulmonary bypass (CPB) and its timing is unpredictable. Patients on the transplant waiting list often have multiple reasons for being anticoagulated. Intraoperative removal of apixaban using CytoSorb seems to be an interestin...

Full description

Bibliographic Details
Main Authors: Anouk Frering, MD, Antoine Abi Lutfallah, MD, Aude Carillion, MD, PhD, Daniel Wendt, MD, Pascal Leprince, MD, PhD, Adrien Bougle, MD, PhD, Guillaume Lebreton, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:JHLT Open
Subjects:
heart transplantation
CytoSorb
direct oral anticoagulants
hemoadsorption
apixaban
cardio-pulmonary bypass
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133424001149

Internet

http://www.sciencedirect.com/science/article/pii/S2950133424001149

Similar Items